FIELD: medicine, experimental medicine.
SUBSTANCE: laboratory animals should be affected twice hypoxically at 5-60-min long interval between impacts due to hermetic chamber till detecting agonal spasmodic attack or respiration cessation. The suggested method enables to approximate experimental model of post-hypoxic encephalopathy to human encephalopathy.
EFFECT: higher efficiency.
2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
METHOD OF INTENSIFICATION OF STEM CELLS MOBILISATION | 2006 |
|
RU2330674C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
CEREBROPROTECTIVE AGENT | 2013 |
|
RU2517282C1 |
AN ANTIHYPOXIC AGENT | 1996 |
|
RU2121357C1 |
AGENT SHOWING NOOTROPIC AND ADAPTOGENIC EFFECT | 1998 |
|
RU2136292C1 |
METHOD FOR MODELING HYPOXIC ENCEPHALOPATHY | 2003 |
|
RU2253152C2 |
Authors
Dates
2004-11-20—Published
2003-02-27—Filed